Related Experiment Video

Updated: May 31, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Associations of HSP90 client proteins in human breast cancer

Christopher Shipp1, Kenneth Watson, Graham Lloyd Jones

  • 1Centre for Bioactive Discovery in Health and Ageing, McClymont Building, University of New England, Armidale, New South Wales, 2351, Australia.

Anticancer Research
|July 9, 2011
PubMed
Abstract

Insights

Heat shock protein 90 (HSP90) interactions with client proteins vary by patient. Geldanamycin resistance and low HSP90 client protein expression may hinder HSP90 inhibitor therapies in breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Heat shock protein 90 (HSP90) is a key therapeutic target in cancer.
  • Specific interactions between HSP90 and its numerous client proteins remain largely uncharacterized.
  • Understanding these interactions is crucial for developing effective HSP90-targeted therapies.

Purpose of the Study:

  • To investigate HSP90 client proteins sensitive to the HSP90 inhibitor geldanamycin.
  • To analyze these interactions in both tumor and healthy breast tissue.
  • To identify potential biomarkers for HSP90-targeted therapy response.

Main Methods:

  • Co-immunoprecipitation and SDS-PAGE were employed to study protein interactions.
  • Western blotting and liquid chromatography-mass spectrometry (LC-MS) were utilized for protein identification.
  • Analysis was performed on breast cancer patient samples.

Main Results:

  • HSP90 client proteins were detected in 7 out of 11 breast cancer patients.
  • Proteins such as HSP40, FKBP52, HSP60, HSP70, HSP105, and lumican were identified as geldanamycin-sensitive HSP90 clients.
  • A cancer-specific protein group was identified in one patient, and geldanamycin resistance was observed in all experiments.

Conclusions:

  • HSP90 exhibits differential and patient-dependent associations with its client proteins.
  • Geldanamycin resistance and limited HSP90 client protein expression can impede the clinical utility of HSP90 inhibitors.
  • Further research is needed to overcome resistance mechanisms and optimize HSP90-targeted cancer treatments.

More Related Videos

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...